Company Filing History:
Years Active: 2021
Title: Adam Daniel McInally: Innovator in Recombinant Protein Production
Introduction
Adam Daniel McInally is a notable inventor based in London, GB. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. His innovative approach has the potential to enhance various applications in the pharmaceutical and biotechnological industries.
Latest Patents
Adam holds a patent for a "Method of producing a recombinant protein." This invention relates to a recombinant signal sequence derived from specific sources. The patent also covers a fusion protein that includes the signal sequence and a recombinant protein. Notably, the recombinant signal sequence can be utilized to control the viscosity of fermentation processes and manage basal expression of the recombinant protein.
Career Highlights
Adam is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where he applies his expertise in biotechnology. His work focuses on advancing methods that improve the efficiency and effectiveness of protein production.
Collaborations
Throughout his career, Adam has collaborated with talented professionals, including Robyn Alexandra Emmins and Gary Brian Finka. These collaborations have contributed to the development of innovative solutions in the field.
Conclusion
Adam Daniel McInally is a distinguished inventor whose work in recombinant protein production showcases his commitment to advancing biotechnology. His contributions are poised to make a lasting impact in the industry.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.